Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Affiliation country
Publication year range
1.
Chin J Integr Med ; 29(12): 1059-1065, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37656413

ABSTRACT

BACKGROUND: Ventricular remodeling after acute anterior wall ST-segment elevation myocardial infarction (AAMI) is an important factor in occurrence of heart failure which additionally results in poor prognosis. Therefore, the treatment of ventricular remodeling needs to be further optimized. Compound Danshen Dripping Pills (CDDP), a traditional Chinese medicine, exerts a protective effect on microcirculatory disturbance caused by ischemia-reperfusion injury and attenuates ventricular remodeling after myocardial infarction. OBJECTIVE: This study is designed to evaluate the efficacy and safety of CDDP in improving ventricular remodeling and cardiac function after AAMI on a larger scale. METHODS: This study is a multi-center, randomized, double-blind, placebo-controlled, parallel-group clinical trial. The total of 268 patients with AAMI after primary percutaneous coronary intervention (pPCI) will be randomly assigned 1:1 to the CDDP group (n=134) and control group (n=134) with a follow-up of 48 weeks. Both groups will be treated with standard therapy of ST-segment elevation myocardial infarction (STEMI), with the CDDP group administrating 20 tablets of CDDP before pPCI and 10 tablets 3 times daily after pPCI, and the control group treated with a placebo simultaneously. The primary endpoint is 48-week echocardiographic outcomes including left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume index (LVEDVI), and left ventricular end-systolic volume index (LVESVI). The secondary endpoint includes the change in N terminal pro-B-type natriuretic peptide (NT-proBNP) level, arrhythmias, and cardiovascular events (death, cardiac arrest, or cardiopulmonary resuscitation, rehospitalization due to heart failure or angina pectoris, deterioration of cardiac function, and stroke). Investigators and patients are both blinded to the allocated treatment. DISCUSSION: This prospective study will investigate the efficacy and safety of CDDP in improving ventricular remodeling and cardiac function in patients undergoing pPCI for a first AAMI. Patients in the CDDP group will be compared with those in the control group. If certified to be effective, CDDP treatment in AAMI will probably be advised on a larger scale. (Trial registration No. NCT05000411).


Subject(s)
Drugs, Chinese Herbal , Heart Failure , Myocardial Infarction , Percutaneous Coronary Intervention , ST Elevation Myocardial Infarction , Humans , ST Elevation Myocardial Infarction/etiology , ST Elevation Myocardial Infarction/therapy , Stroke Volume , Ventricular Remodeling , Prospective Studies , Microcirculation , Ventricular Function, Left , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/drug therapy , Myocardial Infarction/etiology , Treatment Outcome , Percutaneous Coronary Intervention/adverse effects , Heart Failure/diagnostic imaging , Heart Failure/drug therapy , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Randomized Controlled Trials as Topic , Multicenter Studies as Topic
2.
Zhongguo Zhong Yao Za Zhi ; 33(4): 392-6, 484, 2008 Feb.
Article in Chinese | MEDLINE | ID: mdl-18533494

ABSTRACT

OBJECTIVE: To develop the mechanism of improving protection function of prepared Cornus officinalis for liver and kidney and the biological activity of 5-hydroxymethylfurfural (5-HMF). METHOD: Pharmacological and chemical studies were used to choose active part. A compound from active part was separated and appraised. To investigate his biological functions, pharmacological experiment was actualized. RESULT: A component was separated and identified. His is 5-HMF. 5-HMF can protect human vein epidermal cell against H2O2 and glucose and inprove acute liver injury in mice. CONCLUSION: 5-HMF is the active component in prepared Cornus officinalis and substance basis for protecting liver and kidney.


Subject(s)
Cornus/chemistry , Furaldehyde/analogs & derivatives , Animals , Cells, Cultured , Endothelial Cells/drug effects , Female , Furaldehyde/chemistry , Furaldehyde/isolation & purification , Furaldehyde/pharmacology , Liver/drug effects , Male , Mice , Random Allocation
3.
Zhong Yao Cai ; 30(4): 396-9, 2007 Apr.
Article in Chinese | MEDLINE | ID: mdl-17674786

ABSTRACT

OBJECTIVE: To investigate amino acid and inorganic element in cornus officinalis and study the effects of processed on contents of them. METHODS: The amino acid analysis with precolume derivatization was implemented by HPLC and the contents of element in the prevention were determined by ICP. RESULTS: cornus officinalis contained eighteen inorganic element and abundant K, Ca, Mg. After processed, except for Cu, Ba, Ni, all were increased and the contents of La and Ce were added remarkably. Sixteen amino acid were determined in cornus officinalis and rich asp and glu were measurated. The total content of amino acid decreased, but contents of lys, phe and etc. increased. After processed, the contents of met, his were destroyed and pro reduced, however the total content of amino acid increased. CONCLUSION: cornus officinalis contains many types of amino acid and inorganic element. Processing lead to the dissolved of inorganic element increase and change of contents of amino acid. Plenty K, asp and the increase of the contents of lys, leu, val, and etc. being necessary for mamkind may be one of mechanism of enganced effect on protecting liver and kidney.


Subject(s)
Amino Acids/analysis , Cornus/chemistry , Plants, Medicinal/chemistry , Trace Elements/analysis , Amino Acids, Essential/analysis , Chromatography, High Pressure Liquid/methods , Drugs, Chinese Herbal/analysis , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/isolation & purification , Fruit/chemistry , Magnesium/analysis , Potassium/analysis
SELECTION OF CITATIONS
SEARCH DETAIL